Metastasis or the progression of malignancy poses a major challenge in cancer therapy and
is the principal reason for increased mortality. The epithelial-mesenchymal transition (EMT) …

In the era of quantitative proteomics, where mass spectrometry plays a pivotal role, in
particular associated with the use of data‐independent acquisition, it is time to perform an …

Melanoma is a skin cancer with permanently increasing incidence and resistance to
therapies in advanced stages. Reports of spontaneous regression and tumour infiltration …

Gastric cancer is the fifth most common cancer worldwide with a poor survival rate.
Therefore, it is important to identify predictive and prognostic biomarkers of gastric cancer …

Glycosylation is the most frequent and structurally complex posttranslational modification in
cell-surface and secreted proteins. Glycans are major orchestrators of biological processes …

The cellular microenvironment composition and changes therein play an extremely
important role in cancer development. Changes in the extracellular matrix (ECM), which …

Chronic inflammation drives the development of colorectal cancer (CRC), where tumor-
infiltrating immune cells interact with cancer cells in a dynamic crosstalk. Mast cells (MC) …

Introduction: Exploring post-translational modifications (PTMs) with the use of mass
spectrometry (PTMomics) is a rapidly developing area, with methods for discovery …

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Biomarkers
that can facilitate better clinical management of CRC are in high demand to improve patient …

About one million people per year develop colorectal cancer (CRC) and approximately half
of them die. The extent of the disease (ie local invasion at the time of diagnosis) is a key …